drugset / Trial / NCT00372099

Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women

NCT00372099

Phase 3 Completed 90 enrolled Rene Rizzoli
RandomizedParallel-groupDouble-blindTreatment

Summary

Calcitonin has been used for many years for treating osteoporosis in postmenopausal women. Recent data from the 2 years placebo-controlled QUEST study have shown a preservation of microarchitecture as measured by high resolution MRI in postmenopausal women with prevalent vertebral fractures at baseline.This pilot study should provide additional new insights in the mode of action of nasal calcitonin, on structural changes as measured by high resolution peripheral CT, and on the comparison between weight bearing and non weight bearing bones in postmenopausal women.

Timeline

Start
2007-01
Primary completion
2011-10
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject salmon calcitonin Unknown 200 iu Intranasal

Indications

No indication recorded.